Feb 10, 2009 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. FDA has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of GlaxoSmithKline's Imitrex Tablets (sumatriptan succinate), 25 mg, 50 mg and 100 mg for treatment of acute migraine attacks. Shipment of this product has commenced.
The details can be read here.
1 comment:
Nice blog as it is much informative for visitors.
Buy imitrex
Post a Comment